Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression

Clinical trial NCT06180356 · RECRUITING

Trial details

NCT number: NCT06180356
Sponsor: MedSIR
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Oligometastatic Disease Serous Ovarian Tumor

Start date: 2024-12-03
Primary completion: 2028-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.